Healthcare provider profile · identity verified

Mark Virtue, M.D.

Family Practice · ROME, GA · NPI 1497980064

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	488	95
Amlodipine Besylate	Amlodipine Besylate	479	130
Rosuvastatin Calcium	Rosuvastatin Calcium	446	120
Levothyroxine Sodium	Levothyroxine Sodium	413	96
Atorvastatin Calcium	Atorvastatin Calcium	369	104
Pantoprazole Sodium	Pantoprazole Sodium	284	80
Lisinopril	Lisinopril	262	71
Omeprazole	Omeprazole	200	55
Losartan Potassium	Losartan Potassium	187	49
Metoprolol Tartrate	Metoprolol Tartrate	174	44
Metformin Hcl	Metformin Hcl	171	52
Alprazolam	Alprazolam	166	25
Tamsulosin Hcl	Tamsulosin Hcl	163	39
Trazodone Hcl	Trazodone Hcl	157	41
Hydrochlorothiazide	Hydrochlorothiazide	156	47
Citalopram Hbr	Citalopram Hydrobromide	155	47
Hydralazine Hcl	Hydralazine Hcl	147	34
Pravastatin Sodium	Pravastatin Sodium	147	36
Albuterol Sulfate Hfa	Albuterol Sulfate	145	37
Buspirone Hcl	Buspirone Hcl	138	33
Quetiapine Fumarate	Quetiapine Fumarate	137	34
Venlafaxine Hcl Er	Venlafaxine Hcl	136	28
Meloxicam	Meloxicam	133	39
Metoprolol Succinate	Metoprolol Succinate	129	40
Zolpidem Tartrate	Zolpidem Tartrate	127	20
Famotidine	Famotidine	125	31
Potassium Chloride	Potassium Chloride	114	38
Furosemide	Furosemide	110	44
Montelukast Sodium	Montelukast Sodium	109	24
Pregabalin	Pregabalin	108	25
Allopurinol	Allopurinol	101	27
Clonazepam	Clonazepam	98	18
Olmesartan Medoxomil	Olmesartan Medoxomil	97	34
Ozempic	Semaglutide	96	12
Eliquis	Apixaban	91	23
Carvedilol	Carvedilol	90	26
Esomeprazole Magnesium	Esomeprazole Magnesium	85	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	20
Pioglitazone Hcl	Pioglitazone Hcl	81	23
Escitalopram Oxalate	Escitalopram Oxalate	79	21
Fluticasone Propionate	Fluticasone Propionate	79	25
Clopidogrel	Clopidogrel Bisulfate	74	23
Sertraline Hcl	Sertraline Hcl	69	19
Simvastatin	Simvastatin	68	19
Duloxetine Hcl	Duloxetine Hcl	67	14
Lovastatin	Lovastatin	66	12
Mirtazapine	Mirtazapine	65	19
Glipizide	Glipizide	62	18
Bupropion Xl	Bupropion Hcl	60	17
Nebivolol Hcl	Nebivolol Hcl	60	16
Tizanidine Hcl	Tizanidine Hcl	59	21
Januvia	Sitagliptin Phosphate	58	suppressed
Valsartan	Valsartan	58	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	16
Hydroxyzine Pamoate	Hydroxyzine Pamoate	56	18
Prednisone	Prednisone	56	30
Amitriptyline Hcl	Amitriptyline Hcl	55	17
Atenolol	Atenolol	55	16
Topiramate	Topiramate	55	12
Tramadol Hcl	Tramadol Hcl	55	18
Donepezil Hcl	Donepezil Hcl	54	suppressed
Fenofibrate	Fenofibrate	54	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	14
Metformin Hcl Er	Metformin Hcl	50	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	47	17
Mounjaro	Tirzepatide	46	suppressed
Fluconazole	Fluconazole	45	24
Aripiprazole	Aripiprazole	44	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	suppressed
Doxepin Hcl	Doxepin Hcl	42	suppressed
Lamotrigine	Lamotrigine	42	12
Benazepril Hcl	Benazepril Hcl	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	13
Klor-Con M20	Potassium Chloride	39	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	30
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	11
Lorazepam	Lorazepam	37	12
Ondansetron Hcl	Ondansetron Hcl	37	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	14
Glimepiride	Glimepiride	35	suppressed
Glipizide Er	Glipizide	35	suppressed
Levetiracetam	Levetiracetam	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Ibuprofen	Ibuprofen	33	suppressed
Spironolactone	Spironolactone	32	11
Doxycycline Monohydrate	Doxycycline Monohydrate	31	27
Celecoxib	Celecoxib	30	12
Methylprednisolone	Methylprednisolone	28	26
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Brilinta	Ticagrelor	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Colchicine	Colchicine	25	11
Jardiance	Empagliflozin	25	suppressed
Amoxicillin	Amoxicillin	24	17
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Trimethoprim	Trimethoprim	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Levofloxacin	Levofloxacin	23	18
Olanzapine	Olanzapine	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Azithromycin	Azithromycin	22	17
Finasteride	Finasteride	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Eszopiclone	Eszopiclone	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Ramipril	Ramipril	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Cefdinir	Cefdinir	17	16
Cephalexin	Cephalexin	17	15
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Scopolamine	Scopolamine	16	suppressed
Baclofen	Baclofen	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	14	suppressed
Diazepam	Diazepam	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Febuxostat	Febuxostat	14	suppressed
Invokana	Canagliflozin	14	suppressed
Lurasidone Hcl	Lurasidone Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Risperidone	Risperidone	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Vraylar	Cariprazine Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Euthyrox	Levothyroxine Sodium	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Chlorzoxazone	Chlorzoxazone	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Naproxen	Naproxen	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error